Pay in 4 interest-free payments of $6.22 Learn more
Ships within 48 hours · Estimated delivery Oct 21 - Oct 26
In this randomized, double-blind, placebo-controlled, 3-week crossover trial, 34 patients with primary polydipsia received weekly dulaglutide (1.5 mg, Trulicity) in one treatment segment and placebo (0.9% sodium chloride) in the other
doi: 10.3389/fendo.2026.1822475 Received 03 March 2026 Revised 05 May 2026 Accepted 02 June 2026 Published 18 June 2026 Volume 17 - 2026 Edited by Carmine Bruno, Link Campus University, Italy Reviewed by Matej Rakusa, University Medical Centre Ljubljana, Slovenia Fredrik Tiberg, Camurus AB, Sweden Updates Copyright 2026 Dominikowski, Rko, Olejarz, Szczepanek-Parulska, Domin and Ruchaa
Objective measurements Depending on your goals, track relevant objective metrics: Body composition: Weight, body fat percentage, circumference measurements, progress photos Performance: Strength numbers, endurance metrics, recovery indicators Health markers: Blood pressure, fasting glucose, HbA1c if using GH or GLP-1 peptides Healing: Range of motion, pain scales, functional capacity tests The peptides before and after article shows what realistic progress looks like
Cheong JLY, de Pablo-Fernandez E, Foltynie T, Noyce AJ
Atrazine and human health
